ReviewCureus2025
The Efficacy of Ayurvedic Herbs in the Prevention and Treatment of Inflammatory Bowel Disease: A Scoping Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal tract with no known cure in Western medicine. While steroids and other anti-inflammatory treatments help manage symptoms, Ayurvedic herbs and spices offer a holistic approach rooted in Ayurveda, an ancient Indian medical system that aims to balance life's forces (doshas) within the mind, body, and soul. Although certain Ayurvedic herbs have demonstrated anti-inflammatory properties, a comprehensive review of their efficacy in IBD treatment remains limited. This study evaluates the effectiveness of Ayurvedic herbal extracts and formulations in the treatment and prevention of IBD through a review of literature from January 2003 to September 2023 across Embase, PubMed, and Cochrane Central. A total of 25 full-text articles were analyzed, with data compiled based on study characteristics and relevance to the research question. Findings indicate macroscopic, microscopic, and clinically significant benefits, including reduced mucus in stool, improved colonic weight retention, and decreased inflammatory markers such as tumor necrosis factor-α (TNF-α), interleukin-2 (IL-2), prostaglandin E2 (PGE2), and endothelium-dependent relaxation (EDR). Clinically, patients reported fewer urgent bowel movements and an improved sense of well-being. These results suggest that Ayurvedic herbs may serve as a complementary or alternative therapy for IBD, warranting further well-designed clinical trials to fully assess their therapeutic potential.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.